Top Markets
Coin of the day
LigaChem Biosciences Inc. LigaChem Biosciences Inc.

LigaChem Biosciences Inc.

141080
Rank in Stocks #5687
LigaChem Biosciences, Inc. specializes in the development and manufacturing of... LigaChem Biosciences, Inc. specializes in the development and manufacturing of a broad spectrum of medical solutions, encompassing pharmaceuticals, medical devices, and essential healthcare supplies. Their extensive product offerings include various therapeutic agents such as antibiotics, anti-coagulants, and oncology treatments, alongside cutting-edge antibody-drug conjugates and protein-drug conjugates. Established on May 2, 2006, the company's headquarters are situated in Daejeon, South Korea.
Share Price
$68.87
Market Cap
$2.51B
Change (1 day)
1.32%
Change (1 year)
-35.79%
Country
KR
Trade LigaChem Biosciences Inc. (141080)

Category

Operating Margin for LigaChem Biosciences Inc. (141080)
Operating Margin as of 2026 TTM: 0.00%
According to LigaChem Biosciences Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for LigaChem Biosciences Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
-149.01% -
US
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.